CHANEL is a privately held luxury fashion house founded in 1910 by Gabrielle 'Coco' Chanel, specializing in ready-to-wear, fragrances, cosmetics, jewelry, and watches. Through its Open Innovation team, CHANEL makes strategic minority investments in startups aligned with its luxury and sustainability goals.
40% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Their most common stage is series-a (50% of deals). Average disclosed round size is $51.2M (across 8 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PP2 Science Inc. | Unknown | $23M | May 2026 |
| PP2 Science Inc. | Series A | $23M | Feb 2023 |
 The Good Face Project | Seed | $5.7M | Aug 2022 |
 Evolved by Nature | Series C | $120M | Jun 2022 |
| Evolved by Nature | Series B | $70M | Dec 2021 |
 Arcaea | Series A | $78M | Oct 2021 |
| Arcaea | Series A | $78M | Jan 2021 |
| PP2 Science Inc. | Series C | $12M | Jan 2020 |
 Sulapac | Series A | — | Dec 2019 |
 Yangi | Series A | — | — |
Top Co-Investors
BASF Venture Capital3 shared
Connecticut Innovations3 shared
Mousse Partners3 shared
Sofinnova Partners2 shared
GS Futures2 shared
dsm-firmenich Ventures2 shared
GG12 shared
Emerald Technology Ventures2 shared
Ontario Teachers' Pension Plan2 shared
The Kraft Group2 shared
Viking Global Investors2 shared
Givaudan2 shared
Heritage Group1 shared
Lewis & Clark AgriFood1 shared
Blossom Street Ventures1 shared
Senator Investment Group1 shared
Emerald Development Managers1 shared
Ginkgo Bioworks1 shared
Viking Global1 shared
Wittington Ventures1 shared
Last updated: 7 October 2026